Dr. Anton Titov, MD. Hello! Today we are with Dr. David J. Kerr, who is Professor of Cancer Medicine at University of Oxford. Dr. Kerr is also former President of the European Society for Medical Oncology. Dr. David J. Kerr, MD, received his MD from University of Glasgow. Dr. Kerr did his post-graduate training in clinical oncology and cancer research at several leading UK and the USA institutions. Dr. David J. Kerr, MD, has large experience in public health and policy. He served as health adviser to the UK Secretary of Health. He also served as Chief Research Advisor for Sidra Medical and Research Center in Qatar. Clinical and research interests of Dr. Kerr are in colorectal cancer genetics and treatment, and in cancer treatment organizations in the emerging markets. Dr. David J. Kerr, MD, is an author of over 300 peer-reviewed scientific articles on cancer genetics and colorectal cancer. Dr. Kerr, hello and welcome. Dr. David Kerr, MD (Colorectal cancer oncologist, Oxford). Thank you very much for that warm introduction. Dr. Anton Titov, MD. Colorectal cancer treatment changed dramatically over the last decade. What are the major recent advances in colorectal cancer treatment? Leading colorectal cancer expert from Oxford discusses recent advances in colon cancer molecular diagnostics. Precision medicine treatment and prevention of colon cancer and rectal cancer. We also discuss cancer treatment strategies for the developing world and the future in colorectal cancer treatment.